Doris Riether

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

Organic letters

Journal of chemical information and modeling

This page only lists publications with an associated author ORCID identifier.

Publications

Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Anna M Rydzik, Regina Balk, Martin Koegler, Tobias Steinle, Doris Riether, Dirk Gottschling
Access to 1'-Amino Carbocyclic Phosphoramidite to Enable Postsynthetic Functionalization of Oligonucleotides. Organic letters 23 (17) (2021)
Uta Lessel, Marco Ferrara, Niklas Heine, Chiara Marelli, Laura Carrettoni, Roland Pfau, Esther Schmidt, Doris Riether
Identification of Highly Selective Orexin 1 Receptor Antagonists Driven by Structure-Based Design. Journal of chemical information and modeling (2021)

Doris Riether.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Doris Riether